Determinants of premature atherosclerosis in children with end-stage renal disease

Area of Science:

• Pediatric Nephrology
• Cardiovascular Research
• Atherosclerosis Studies

Background:

• Cardiovascular disease (CVD) is a leading cause of death in young adults with end-stage renal disease (ESRD).
• The underlying mechanisms of CVD in pediatric ESRD patients remain poorly understood.
• Early detection and understanding of atherosclerosis determinants are crucial in this population.

Purpose of the Study:

• To investigate the determinants of preclinical atherosclerosis in children with end-stage renal disease (ESRD).
• To compare markers of atherosclerosis between children with ESRD and healthy controls.
• To identify biochemical and anthropometrical factors associated with atherosclerosis in pediatric ESRD.

Main Methods:

• Ultrasound measurement of common carotid intima-media thickness (CIMT) as a marker of atherosclerosis.
• Comparison of 37 children with ESRD (31 post-transplant) to 22 healthy children.
• Evaluation of associations between CIMT and various clinical parameters including blood pressure, lipids, and biochemical markers.

Main Results:

• Children with ESRD exhibited significantly higher CIMT, blood pressure, lipoprotein (a), urea, creatinine, ferritin, homocysteine, and serum uric acid.
• Patients with ESRD had lower apolipoprotein A levels and a borderline significantly higher atherogenic index of plasma.
• Negative correlations between CIMT and serum albumin/bilirubin, and a positive correlation with ferritin in controls were observed.

Conclusions:

• Children with ESRD demonstrate accelerated atherosclerosis, evidenced by increased CIMT.
• Factors beyond traditional cardiovascular risk factors, potentially including reduced anti-oxidative capacity, play a role in early atherosclerosis in pediatric ESRD.
• Further research into non-traditional markers is warranted for managing CVD risk in this vulnerable group.